title: Anti-HER2 immunoliposomes for targeted drug delivery.
authors.affiliation: California Pacific Medical Center Research Institute, San Francisco 94115, USA. khong@cooper.cpmc.org
authors.forename: K
authors.initials: K
authors.lastname: Hong
authors.forename: D B
authors.initials: DB
authors.lastname: Kirpotin
authors.forename: J W
authors.initials: JW
authors.lastname: Park
authors.forename: Y
authors.initials: Y
authors.lastname: Shao
authors.forename: R
authors.initials: R
authors.lastname: Shalaby
authors.forename: G
authors.initials: G
authors.lastname: Colbern
authors.forename: C C
authors.initials: CC
authors.lastname: Benz
authors.forename: D
authors.initials: D
authors.lastname: Papahadjopoulos
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004337:Drug Carriers; D006801:Humans; D008081:Liposomes; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology*
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D008081:Liposomes; D018719:Erb-b2 Receptor Tyrosine Kinases